Cook Group Incorporated
Family-owned diversified group headquartered in Bloomington, Indiana, originally established in medical devices. The organization operates companies across medical devices, life sciences, manufacturing services, property management, resorts, and aviation. It provides device design and manufacturing, clinical and regulatory services, biomaterials development, and local community programs. The group reports global operations employing over 12,000 people.
Industries
Nr. of Employees
small (1-50)
Cook Group Incorporated
P.O. Box 1608, Bloomington, Indiana 47402-1608 USA
Products
Minimally invasive device components (needles, wire guides, catheters)
Device components and systems intended for minimally invasive procedures across multiple clinical specialties.
Regenerative surgical graft materials (processed xenograft biomaterials)
Processed animal-derived tissue materials used as surgical grafts and regenerative matrices.
Blood-derived cell concentration system for therapeutic use
A device/system that concentrates peripheral blood nucleated cells for subsequent therapeutic intramuscular administration in ischemic limbs.
Minimally invasive device components (needles, wire guides, catheters)
Device components and systems intended for minimally invasive procedures across multiple clinical specialties.
Regenerative surgical graft materials (processed xenograft biomaterials)
Processed animal-derived tissue materials used as surgical grafts and regenerative matrices.
Blood-derived cell concentration system for therapeutic use
A device/system that concentrates peripheral blood nucleated cells for subsequent therapeutic intramuscular administration in ischemic limbs.
Services
Regulatory strategy, clinical study design, and support services to accelerate device development from concept to clinical use.
Production of stainless-steel tubing and other components for medical device assembly and industrial customers.
Organization of in-person and virtual events with registration, travel arrangements, recordings, and post-event follow-up.
Regulatory strategy, clinical study design, and support services to accelerate device development from concept to clinical use.
Production of stainless-steel tubing and other components for medical device assembly and industrial customers.
Organization of in-person and virtual events with registration, travel arrangements, recordings, and post-event follow-up.
Expertise Areas
- Medical device research and manufacturing
- Clinical trial management and execution
- Regulatory strategy and compliance
- Biomaterials and regenerative medicine
Key Technologies
- Minimally invasive medical device design
- Xenograft biomaterial processing
- Autologous cell concentration and preparation
- Therapeutic infusion and delivery hardware
News & Updates
Agreement to sell a former GE manufacturing facility parcel; retained adjacent parcel for company use. Transaction closed July 24 and will support local life sciences industry growth.
Agreement for the acquisition of a biomaterials-focused life sciences company by a surgical implant firm; transition services to be provided during integration.
Enrollment of first patient in an international randomized controlled trial evaluating a blood filtration system that produces autologous cell concentrates for intramuscular injection in CLI patients.
Statement addressing recent incidents of racial violence and outlining commitments to expand community programs, remove barriers to education and housing, and improve support for people of color.
Overview of corporate COVID-19 operations plan and shared materials/webinar describing policies for workplace safety, sanitization, and phased return to work.
Recognition for a workforce development and education assistance program that provided employees access to education and career advancement opportunities.
Agreement to sell a former GE manufacturing facility parcel; retained adjacent parcel for company use. Transaction closed July 24 and will support local life sciences industry growth.
Agreement for the acquisition of a biomaterials-focused life sciences company by a surgical implant firm; transition services to be provided during integration.
Enrollment of first patient in an international randomized controlled trial evaluating a blood filtration system that produces autologous cell concentrates for intramuscular injection in CLI patients.
Statement addressing recent incidents of racial violence and outlining commitments to expand community programs, remove barriers to education and housing, and improve support for people of color.
Overview of corporate COVID-19 operations plan and shared materials/webinar describing policies for workplace safety, sanitization, and phased return to work.
Recognition for a workforce development and education assistance program that provided employees access to education and career advancement opportunities.